Stage IIIA Skin Melanoma Active Not Recruiting Phase 1 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01940809Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by SurgeryTreatment
NCT02097225Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTreatment